Thus, CD19.CAR NK cells co-expressing IL15/IL15Rα exhibited superior antitumor activity against lymphoma cells in vivo compared to CAR construct co-expressing soluble IL-15 or no cytokines. The gene discussed is IL15; the disease is lymphoma.